SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-008178
Filing Date
2024-03-01
Accepted
2024-03-01 16:01:21
Documents
94
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vyne-20231231.htm   iXBRL 10-K 1939411
2 EX-10.3 exhibit103-vynexcowensales.htm EX-10.3 314768
3 EX-10.17 exhibit1017-nonxemployeedi.htm EX-10.17 16837
4 EX-21.1 exhibit211listofsubsidiari.htm EX-21.1 3594
5 EX-23.1 exhibit231consentus12312023.htm EX-23.1 2176
6 EX-31.1 vyne-20231231xexx311.htm EX-31.1 10727
7 EX-31.2 vyne-20231231xexx312.htm EX-31.2 10721
8 EX-32.1 vyne-20231231xexx321.htm EX-32.1 6883
9 EX-32.2 vyne-20231231xexx322.htm EX-32.2 6850
10 EX-97.1 exhibit971-vynerecoupmentp.htm EX-97.1 35125
16 vyne-20231231_g1.jpg GRAPHIC 250638
17 vyne-20231231_g2.jpg GRAPHIC 583988
  Complete submission text file 0001628280-24-008178.txt   10698519

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20231231.xsd EX-101.SCH 55455
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20231231_cal.xml EX-101.CAL 85087
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20231231_def.xml EX-101.DEF 341161
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20231231_lab.xml EX-101.LAB 719164
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20231231_pre.xml EX-101.PRE 518382
96 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20231231_htm.xml XML 854928
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38356 | Film No.: 24709428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)